When was Levitate Bio founded?

Levitate Bio was founded in 2024.

Where is Levitate Bio located?

Levitate Bio is headquartered in Kirkland, United States.

Where does Levitate Bio rank among its competitors?

Levitate Bio ranks 6th amongst 10 active competitors, of which 4 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was LiteFold, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Levitate Bio?

Levitate Bio's top competitors include TernaryTx, Avilar and Epsilico. Among them, LiteFold secured the most recent funding round in May, 2026.

Levitate Bio - 2026 Company Profile, Team & Competitors

Company Details

Platform offering automated and customized AI solutions for biopharma drug discovery. It provides protocols and automated solutions for non computational biologists, specializing in cell isolation and enrichment. It offers a range of protocols for protein design, structure prediction, and analysis, including De Novo Design, Mutation Sampling and design, protein structure prediction, and protein structure optimization.

Website: levitate.bio
Email ID: *****@levitate.bio

Key Metrics

Founded Year

2024

Location

Kirkland, United States

Stage

Unfunded

Ranked

6^th among 10 active competitors

Similar Companies

TernaryTx & 8 more

View Levitate Bio's full profile

Levitate Bio has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Levitate Bio include TernaryTx, Avilar and Epsilico. Here is the list of Top 10 competitors of Levitate Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TernaryTx 2024, London (United Kingdom), Seed	Developer of computational platform for molecular glue discovery and design	$4.76M	Daphni, Pace Ventures & 2 others	42/100
2nd	Avilar 2020, Waltham (United States), Seed	Provider of drug discovery platform and protein degradation technology	$75.3M	Sanofi Ventures, Astellas Venture Management ... & 2 others	40/100
3rd	Epsilico 2020, Berlin (Germany), Seed	Generative AI technology for designing biologics	-	Life Science Valley, Europa & 1 others	36/100
4th	iN Therapeutics 2020, Yongin (South Korea), Funding Raised	Developer of drugs for patients with rare neurological diseases	-	E&Venture Partners, Korea Omega Investment Corp	32/100
5th	LiteFold 2025, Dover (United States), Seed	AI platform focused on accelerating protein engineering and drug discovery workflows	-	3F VC, Mercatus	30/100
6th	Levitate Bio 2024, Kirkland (United States), Unfunded	Platform offering automated and customized AI solutions for biopharma drug discovery	-	-	26/100
7th	Interdict 2022, San Francisco (United States), Funding Raised	Developer of a small molecule therapeutics platform to address undruggable targets	-	Altitude Life Science Ventures	24/100
8th	Ubiquitx 2021, Cambridge (United States), Funding Raised	Developer of AI-powered platform for targeted protein degradation therapeutics design	-	E14 Fund, HHS	22/100
9th	FuturedMe 2018, Tokyo (Japan), Funding Raised	Developer of platform for protein degradation for development of small molecule based drug	-	JAFCO Group	22/100
10th	Adhesion Therapeutics 2024, Graz (Austria), Funding Raised	AI-enabled molecular glue degraders aimed at treating diseases	-	Europa	15/100